BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 16328067)

  • 1. BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines.
    Lang C; Stickler S; Rath B; Teufelsbauer M; Weigl L; Hohenegger M; Hamilton G
    Anticancer Res; 2024 Mar; 44(3):971-980. PubMed ID: 38423674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic Effects of Castalin Nanoparticles Against Osteosarcoma.
    Zhang S; Ren H; Sun HT; Cao S
    Appl Biochem Biotechnol; 2023 Sep; 195(9):5355-5364. PubMed ID: 35226253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Datasets for the effects of RUNX2 silencing on transcriptomic and metabolomic profiles in SJSA-1 osteosarcoma cells.
    Le MNU; Chen R; Xia LE; Zhou J; Ning Y
    Data Brief; 2023 Oct; 50():109500. PubMed ID: 37663774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-energy shock waves promote the cisplatin chemosensitivity of human osteosarcoma MNNG/HOS cells via the P2X7/Akt/mTOR pathway.
    Gai N; Ju WN; Yu TC; Qi BC
    Ann Med Surg (Lond); 2024 May; 86(5):2665-2670. PubMed ID: 38694312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radial shock waves prevent growth retardation caused by the clinically used drug vismodegib in ex vivo cultured bones.
    Ramesh S; Sävendahl L; Madhuri V; Zaman F
    Sci Rep; 2020 Aug; 10(1):13400. PubMed ID: 32770014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.
    Marano F; Rinella L; Argenziano M; Cavalli R; Sassi F; D'Amelio P; Battaglia A; Gontero P; Bosco O; Peluso R; Fortunati N; Frairia R; Catalano MG
    PLoS One; 2016; 11(12):e0168553. PubMed ID: 28002459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate.
    Qi B; Yu T; Wang C; Wang T; Yao J; Zhang X; Deng P; Xia Y; Junger WG; Sun D
    J Exp Clin Cancer Res; 2016 Oct; 35(1):161. PubMed ID: 27716441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro cell treatment with focused shockwaves-influence of the experimental setup on the sound field and biological reaction.
    Dietz-Laursonn K; Beckmann R; Ginter S; Radermacher K; de la Fuente M
    J Ther Ultrasound; 2016; 4():10. PubMed ID: 27030807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapy of osteogenic sarcoma: current status and thoughts for the future.
    Friedman MA; Carter SK
    J Surg Oncol; 1972; 4(5):482-510. PubMed ID: 4566220
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the treatment of osteosarcoma.
    Chang P
    Med Clin North Am; 1977 Sep; 61(5):1027-38. PubMed ID: 408567
    [No Abstract]   [Full Text] [Related]  

  • 11. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
    Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
    Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
    Pasello M; Hattinger CM; Stoico G; Manara MC; Benini S; Geroni C; Mercuri M; Scotlandi K; Picci P; Serra M
    Eur J Cancer; 2005 Sep; 41(14):2184-95. PubMed ID: 16140527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.